Schedule 13G ownership disclosure

CONDUIT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 20678X106

Event date: 2024-08-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,504,465
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-107836
Form type
SC 13G
Filer
ASTRAZENECA PLC
CIK
CIK 901832
Filed
Oct 11, 2024
Reporting period
Aug 07, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub